About Us
Founded in 1944, the American Committee for the Weizmann Institute of Science develops philanthropic support for the Weizmann Institute in Israel, and advances its mission of science for the future of humanity.
Sep 06, 2023... Scientists grow whole model of human embryo, without sperm or egg
Sep 07, 2023... Lab-grown human "embryo-like structures" bring hope for research into early-pregnancy complications
https://www.weizmann-usa.org/news-media/news-releases/toward-a-treatment-for-huntington-s-disease/
Feb 27, 2024...
REHOVOT, ISRAEL—February 27, 2024—The human brain is a well-guarded control center. Its system of blood vessels is surrounded by a densely packed cellular barrier that prevents most substances from getting in or out. This fortified architecture protects the brain, but it can also stop it from getting help when needed – as in the case of a neurodegenerative disease.
In a new study published in EMBO Molecular Medicine, Prof. Rivka Dikstein of the Weizmann Institute of Science and her team identified two small molecules that manage to penetrate the blood-brain barrier and reduce the levels of a defective protein that causes Huntington’s disease, an incurable neurodegenerative disorder. The new drugs not only slowed the progress of the disease in mouse models but even reversed some of its symptoms.
Mar 18, 2024... REHOVOT, ISRAEL—March 18, 2024—Researchers at the Weizmann Institute of Science have identified a yeast that might be used to prevent invasive candidiasis, a major cause of death in hospitalized and immunocompromised patients. The study, published today in the Journal of Experimental Medicine (JEM), shows that the novel yeast lives harmlessly in the intestines of mice and humans, and – as has so far been shown in laboratory animals – it can displace the yeast responsible for candidiasis, Candida albicans.